Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: ORENCIA (abatacept) (orencia.com)
ORENCIA delivers a Moderate BS Score of 49, buoyed by real-world regulatory constraints but dragged down by stale statistical data and zero technical schema. It successfully avoids the ‘revolutionary’ fluff of smaller biotech sites by leaning on its status as a 20-year-old incumbent, though the ‘reviews’ without proof links are pure trust theatre. The biosimilar defense is its only high-substance clinical differentiator.
Medical Devices, Pharma & Biotech Reputation: ORENCIA (abatacept) (orencia.com)
The site strongly matches the Pharmaceutical and Biotech industry. The content is heavily regulated, focusing on indications, usage instructions, and required safety information (ISI) for an FDA-approved biologic treatment.
“The score was primarily driven by the Identity and Authority pillar (11/15) due to the total absence of schema markup, and the Trust and Proof pillar (14/20) due to the combination of high review counts without any verifiable external proof links. Information density was penalized for concept repetition and stale 11-year-old survey data.”